Clinical catecholamine neurochemistry: a legacy of Julius Axelrod.

被引：12

作者：

David S. Goldstein ^{[1
]}

Graeme Eisenhofer ^{[2
]}

Irwin J. Kopin ^{[1
]}

机构：

[1] Clinical Neurocardiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, 20892-1620, Maryland

来源：

Cellular and Molecular Neurobiology | 2006年 / 26卷 / 4期

关键词：

catecholamine; norepinephrine; epinephrine; adrenaline; metane-phrine; normetanephrine; positron emission tomography; pheochromocytoma; dihydroxy phenylglycol; phenylethanolamine-N-methyltransferase; catechol-O-methyltransferase; sympathetic nervous system;

D O I：

10.1007/s10571-006-9041-0

中图分类号：

学科分类号：

摘要：

1. Discoveries, insights, and concepts that Julius Axelrod introduced about the disposition and metabolism of catecholamines provided the scientific basis and spurred the development of clinical catecholamine neurochemistry. 2. Here, we provide examples of this aspect of Axelrod's scientific legacy.

引用

页码：695 / 702

页数：7